Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.
about
Tuberculosis therapy for 2016 and beyond.Augmented trial designs for evaluation of principal surrogates.Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infectionsLinezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.Linezolid Toxicity and Mitochondrial Susceptibility: A Novel Neurological Complication in a Lebanese Patient.Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.Challenges and recent progress in drug discovery for tropical diseases
P2860
Q30248788-C6327E86-0F83-4D07-8E48-9E9DFF7D1F92Q37025729-143C2FE8-EA71-485B-93E7-21DEA63888D4Q37339287-1A77A9E2-BA22-4B55-91AB-8FFE011B9E0AQ38929509-255C200B-FEA4-412D-8D02-1AC27A31DA20Q39067666-B1189E2F-E9E5-4881-AAC7-C42958949057Q40184248-13E9DB66-5444-4757-863E-49E8975B5C6AQ41131005-8B242E06-D6D8-4BC5-BA71-A9CD2CB9DA8DQ47339328-41D34EE2-3E25-4C87-BF39-BF7F30E27434Q50082653-98853A49-469C-4980-8BA3-E4F4E057062FQ50719557-46BD0783-F8B8-45F9-857D-48D8CA210226Q53698038-DB34788A-540B-48B9-81C1-6FE4D67FE4F7Q55547799-84386959-D536-45C3-90F5-9D49C23B4574Q59073293-5312D4E7-2C3B-4D1C-83BA-3060E4909E7C
P2860
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@ast
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@en
type
label
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@ast
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@en
prefLabel
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@ast
Linezolid Trough Concentration ...... y Drug-Resistant Tuberculosis.
@en
P2093
P2860
P1433
P1476
Linezolid Trough Concentration ...... ly Drug-Resistant Tuberculosis
@en
P2093
Clifton E Barry
Dean Follman
Han-Seung Jeon
Kenneth N Olivier
Laura E Via
Lisa C Goldfeder
Lori E Dodd
Myungsun Lee
Ray Y Chen
P2860
P304
P356
10.1016/J.EBIOM.2015.09.051
P50
P577
2015-10-09T00:00:00Z